• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Assessing the invasive and metastatic potential of cancer cells from a tissue section

Bioengineer by Bioengineer
March 25, 2022
in Biology
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Rac and Cdc42* are well-studied low molecular weight G proteins that regulate the ability of cancer cells to move, which is called their motility and invasive capacity. The more active these molecules are, the greater the ability of cancer cells to move. This also makes it more likely that diseased cells will invade and metastasize in blood and lymph vessels.

A novel technique to evaluate the invasive and metastatic potential of cancer cells

Credit: Tsuda, M., Horio, R., Wang, L., et al. in Scientific Reports

Rac and Cdc42* are well-studied low molecular weight G proteins that regulate the ability of cancer cells to move, which is called their motility and invasive capacity. The more active these molecules are, the greater the ability of cancer cells to move. This also makes it more likely that diseased cells will invade and metastasize in blood and lymph vessels.

Until now, the motility and invasive capacity of cancer cells had only been assessed biochemically with a method called Rac/Cdc42 pull-down assay. However, when using this approach, the positional information within the cancer tissue is completely lost, and it is also impossible to evaluate the heterogenicity of the cells (how different they are from each other).

Fortunately, and for the first time ever, a research group including Professor Shinya Tanaka and Associate Professor Masumi Tsuda of the Department of Cancer Pathology, Faculty of Medicine, Hokkaido University/Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), managed to successfully evaluate the motility and invasive capacity of cancer cells in cancer tissue sections removed from colorectal cancer patients. The study has been published in Scientific Reports.

The researchers used a recently developed non-contact agitation technology in which alternating electrical fields are used to ‘stir’ liquid droplets at extremely high speeds. With this approach, the group found that they were able to rapidly and specifically evaluate the motility and invasive ability of colon cancer cells by agitating a solution containing molecular probes that bind to activated Rac/Cdc42 on cancer tissue sections. Such sections are called formalin-fixed paraffin-embedded (FFPE) specimens and are routinely used for physical diagnosis.

Their evaluations revealed many insights about the Rac/Cdc42 activity of cells. (a) First, that it was significantly higher in the tumor area than in the normal mucosa of the colon. (b) Moreover, the more advanced the cancer cell stage, the greater the increase in Rac/Cdc42 activity. (c) This increase was particularly high at the leading edges of the tumor, where cancer cells infiltrate the surrounding healthy tissue. (d) Additionally, in cases where Rac1/Cdc42 activity was high, there was a strong tendency for lymphatic invasion.

According to Associate Professor Masumi Tsuda, “While developing this technique, we found it difficult at first to suppress the staining background and detect specific signals. This technology is effective for breast cancer and brain tumors as well as colorectal cancer, and it promises to provide useful information for predicting lymph node metastasis and for the assessment of Rac inhibitor-based therapies in the future.”

***

Footnote

*Rac/Cdc42: Major members of the Rho family of low molecular weight G proteins. They become active upon binding with GTP (guanosine triphosphate), and are inactivated upon binding with GDP (guanosine diphosphate). The motility and invasive ability of cancer cells are increased by activated Rac/Cdc42.

 

References                            

DOI: https://doi.org/10.1038/s41598-022-05892-7 

Original Japanese article published in the March 4th edition of the Science News: https://sci-news.co.jp/

Science Japan URL: https://sj.jst.go.jp/news/202203/n0324-04k.html

 

About Science Japan

Science Japan is a science news site that provides recent news and stories from Japan’s leading research institutes. It is run by the Asia Pacific Research Centre as part of the Japan Science and Technology Agency (JST), one of Japan’s largest funding agencies, with a focus on information and collaboration within the Asia and Pacific regions. 

Science Japan’s goal is to deliver news and information to English speakers around the world with an interest in Japan and its science and technology industries. Daily updates include the latest research news from Japan, and interviews and stories from leading scientists in the region.

Website: https://sj.jst.go.jp/

Facebook: https://www.facebook.com/ScienceJapanJST

Twitter: https://twitter.com/ScienceJapanJST



Journal

Scientific Reports

DOI

10.1038/s41598-022-05892-7

Method of Research

Experimental study

Subject of Research

Human tissue samples

Article Title

Novel rapid immunohistochemistry using an alternating current electric field identifies Rac and Cdc42 activation in human colon cancer FFPE tissues

Article Publication Date

2-Feb-2022

COI Statement

The authors declare no competing interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

Atlas Reveals Testicular Aging Across Species

Atlas Reveals Testicular Aging Across Species

October 2, 2025
Stem Cell Reports Announces New Additions to Its Editorial Board

Stem Cell Reports Announces New Additions to Its Editorial Board

October 2, 2025

New Insights on Bluetongue Virus in South Asia

October 2, 2025

Ancient Ear Bones Rewrite the Story of Freshwater Fish Evolution

October 2, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    92 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    83 shares
    Share 33 Tweet 21
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Countries with Highest Hearing Loss Rates Show Lowest Hearing Aid Usage

Home-Based Early Medical Abortion Up to 12 Weeks: Safe, Effective, and on Par with Hospital Care

Stable Sodium-Ion Battery Cathode: K-rich Copper Hexacyanoferrate

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.